Throughout the Cullen College of Engineering new faces and brilliant minds are joining the faculty in the 2017-2018 school year. The Cullen College proudly welcomes them to its ranks of excellence in academia.

The National Science Foundation has awarded $510,000 to Peter Vekilov, John and Rebecca Moores Professor of chemical and biomolecular engineering and chemistry, to conduct the first fundamental work about how the nature of solvents impact the crystallization process.

The scientist who made the first advancement in the treatment of kidney stones in three decades, Jeffrey Rimer, Ernest J. and Barbara M. Henley Associate Professor of chemical and biomolecular engineering, has been awarded for his work two more times.

For ten weeks during the summer, 12 undergraduate students from across the country are getting the chance of a lifetime on the UH campus, becoming engineering researchers in the Cullen College’s Research Experience for Undergraduates (REU).

More than 500 guests honored the memory and legacy of dedicated UH alumnus and long-time supporter William A. Brookshire at a memorial service held in his honor this summer. The Brookshire Memorial Service was held at the UH Student Center on May 19, nearly one month after Brookshire’s passing in April.

In 2015 the Nobel Prize in Physiology or Medicine went to Chinese scientist Youyou Tu for her discovery of a novel malaria treatment rooted in traditional Chinese medicine. Tu isolated the drug artemisinin from an herb used to treat malaria in China for more than 2,000 years.

The 2017 UH Cullen College of Engineering Alumni Awards Gala was held at the Bayou City Event Center on Thursday, June 8, 2017. The annual event, hosted by the Engineering Alumni Association (EAA), celebrates the professional achievements and contributions of college alumni and faculty.

The Gulf Coast has been spared a major hurricane in the past few years, but as most Houstonians know all-too-well, the wrath of Mother Nature is never far away.

Immunotherapy, in which cells from the human immune system are unleashed to fight disease, has been the big story in cancer treatment over the past few years. When it works, it can spur long-lasting remission in patients for whom other treatments have failed. But most patients don’t benefit, and there is still no good way to predict who will respond.